ESTROGEN RECEPTOR-POSITIVE BREAST CARCINOMA
Clinical trials for ESTROGEN RECEPTOR-POSITIVE BREAST CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new ESTROGEN RECEPTOR-POSITIVE BREAST CARCINOMA trials appear
Sign up with your email to follow new studies for ESTROGEN RECEPTOR-POSITIVE BREAST CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Can a mushroom shrink breast tumors before surgery? new trial investigates
Disease control Recruiting nowThis study tests whether turkey tail mushrooms can help treat a common type of breast cancer in post-menopausal women. About 40 women will take the mushroom supplement in the weeks between diagnosis and surgery. Researchers will measure changes in a tumor growth marker (Ki-67) an…
Matched conditions: ESTROGEN RECEPTOR-POSITIVE BREAST CARCINOMA
Phase: PHASE2 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated May 20, 2026 11:56 UTC
-
New radiation approach may let breast cancer patients keep current therapy longer
Disease control Recruiting nowThis study tests whether a precise type of radiation (SBRT) can control limited cancer growth in people with ER+ metastatic breast cancer, allowing them to continue their current medication instead of switching. It also evaluates a special PET scan (FES) to better detect where th…
Matched conditions: ESTROGEN RECEPTOR-POSITIVE BREAST CARCINOMA
Phase: PHASE2 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated May 19, 2026 12:01 UTC
-
Could a lower tamoxifen dose prevent breast cancer in High-Risk women?
Prevention Recruiting nowThis study is for premenopausal women at higher-than-average risk for breast cancer. It tests whether a low dose of tamoxifen, adjusted based on each woman's response, can safely reduce breast density—a key risk factor for breast cancer. About 200 women will take part, and the go…
Matched conditions: ESTROGEN RECEPTOR-POSITIVE BREAST CARCINOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Prevention
Last updated May 26, 2026 03:33 UTC
-
Can better skin boost confidence in breast cancer survivors?
Symptom relief Recruiting nowThis study looks at how skin quality and self-esteem change in breast cancer survivors who are starting a type of hormone therapy called aromatase inhibitors. About 35 women with early-stage breast cancer will join. Researchers will use special imaging to track skin changes and s…
Matched conditions: ESTROGEN RECEPTOR-POSITIVE BREAST CARCINOMA
Sponsor: Mayo Clinic • Aim: Symptom relief
Last updated May 26, 2026 03:32 UTC
-
Ancient mushroom tested for cancer treatment side effects
Symptom relief Recruiting nowThis study tests whether Reishi mushroom extract can reduce fatigue and joint/muscle pain in breast cancer patients taking aromatase inhibitors. These side effects often cause patients to stop a helpful medication. The trial will involve 80 adults with ER-positive breast cancer w…
Matched conditions: ESTROGEN RECEPTOR-POSITIVE BREAST CARCINOMA
Phase: PHASE2 • Sponsor: Mayo Clinic • Aim: Symptom relief
Last updated May 26, 2026 03:30 UTC
-
CBD extract tested to ease joint pain in breast cancer survivors
Symptom relief Recruiting nowThis study tests a high-CBD plant extract (BRC-001) to see if it can reduce joint pain and stiffness in women with breast cancer who take aromatase inhibitors (AIs). AIs lower estrogen to prevent cancer return but often cause arthritis-like side effects, leading some women to sto…
Matched conditions: ESTROGEN RECEPTOR-POSITIVE BREAST CARCINOMA
Phase: PHASE2 • Sponsor: City of Hope Medical Center • Aim: Symptom relief
Last updated May 13, 2026 15:59 UTC